<VariationArchive RecordType="classified" VariationID="6149" VariationName="NM_001001433.3(STX16):c.145-2060_556+343del" VariationType="Deletion" Accession="VCV000006149" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-09-03" DateCreated="2013-04-04" MostRecentSubmission="2023-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21188" VariationID="6149">
      <GeneList>
        <Gene Symbol="STX16" FullName="syntaxin 16" GeneID="8675" HGNC_ID="HGNC:11431" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58651283" stop="58679526" display_start="58651283" display_stop="58679526" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57226308" stop="57254581" display_start="57226308" display_stop="57254581" Strand="+" />
          </Location>
          <OMIM>603666</OMIM>
        </Gene>
        <Gene Symbol="STX16-NPEPL1" FullName="STX16-NPEPL1 readthrough (NMD candidate)" GeneID="100534593" HGNC_ID="HGNC:41993" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58651253" stop="58715844" display_start="58651253" display_stop="58715844" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001001433.3(STX16):c.145-2060_556+343del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58665428" stop="58669794" display_start="58665428" display_stop="58669794" variantLength="4367" positionVCF="58665427" referenceAlleleVCF="CCTTTGAGGGTGGAAGGGGTTTCTGGAGTCAGCCGACCCAGGTTTCAGTCTGTCACATAATGGCTCTGTGACCTTGGGCAAGCGACTTAACTTTTCTGAGTTTCAATTTCCATATTTATAGGTTAGAATAATAGTTTCTAACTCACCTAGTTTTTATGAGGATTAAAATAATGTCAAGAATGTAAAATTCCTATTGATGAACTCTTGAAACCAAACAGAAGGTAGTGGTGGTGGAGAATTACCACTTCACGGCCCGGGAGCCCCAGACAGTGCGGGTTTGGATGACACACCATTTGTTTAAGAAATGACACTGGCCCTGCAGCATCCGTGCCACGCTTGAGCACCGTTGGGCTTAATCACGGCTCCTGGACGTGCTGGGATTAGTGAATGGGGCCTAGTCCTTCCAGCGTGGTCATTGCCTAAGATGCGTTCCCTGAGTGGACACGTGCCCCAGAGCACACAGAAAGCCTGAAGCAGATGGTGGCAGAACCACTCCAGGGCATGCAGGGAGGTTGATGGTGAAGATACCAATTTGCTTTTAAGAATTTTACTGTGAACTCTTTAGGATTTAGGGCCTATTACTTGAAGTGGTCTTTTATTCTAAGTTTTTCTTTATATGATATTTTTCCCCCTTCATCTGTGGATTTTAAAATTTTGTCTTGTTCCTTTATTATTAGAAAAGCAAATAAGTATTTAATGAATGAAAAAATAAATTTAGTTAAATGCAAGGAAGAGGGAAGAAAAGCAATATGAATTTTTCACCCAACTCTACAGTGTGATTTAGAAAATTTCCAAAGTATTATCTATAAAGGGCTTTTATAGATTATTTTCCATTATATTTTGATCATCATTTGGATCTTTTGAAACTGGCATTTAAAAATTCTGAGCTCTGGAGGGCACCTCAAAATCTTTTCAACCCATTCACTGCCTGCAGGCAAGAAAACAGCTTAACCGTGCCAAACCCATGATTTCCCTCTGTTTTTTGTGTGTGTGTGTGTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTTTCGCTCTTGTTGCCCTGGCTGGAGTGCAATGGTACGATCATGGCTCACTGCGACCTTCGCCTCTTGGGTTCAAGGGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGCATAAGCCACCATGCCCAGTTAATTTTTGTATTTTTAGTAGAGAACGGTTTTCACCATTTTGGCCAGGCTACTCTCGAACTCCTGACCTCAGATGATCTGCCCGCCTTGGCCTCCCAAAGTTCTGGGATTACAGGCGTGAGCCACCGCGCCCAGCCGATTTCCCTCCCATTCTTAAAAGCTTTCTACCGCAGTGTGTTATATAGTTAAAATAAACAGGAACCATCGATACCATTTCAAAATAAGGGGAAATGTTCCCTGTGGACATTTAACTGAAGAAAAGAAATGACAGTGTAAGATTGCATTGAGATCTTAAGGATTGCTTTTGCCAAATGGTAGATAATTTGCTAGCGGTTTTAGGCAGTTGTTTCACACATCTTAACACATGGTTAATGATTGTGTGACTGAGATAACTGGATCAGCCCTATTTCCAAAATAAGCTAAGTGTATTTAAGTAAACCTTGCTACTATTGAGCATTTTGTAGTTGTTTCATTTACTGCCTAGTTTTTTTTTTCACTTGCAACTGATCACAAGAATCATTGAGGTTCATGCCGTTCTATCACAGTACTAGTAGTAAGAGGTCTTTATTTTAAGGATCTTTTGTTGACTTTTTCATTACATTTCTATAGCCAGATCAAGTCAAATTTACGTTCTGAAGTATGTCCAAGGAAATTAAGAGCTGGTGCATGAAAAGATAGGAAAACAATCCAAATCCTAGCAGTTATCAAAAGCAAGTTTATAATACAGGCAAGTGCATTCACTCCTTTCTATATATTTTCAGGGAGCAACATTTAAGAGAGAGTAAACATTCACTCCTTTCTGTATCTTTTCAGGGAGTAACATTTAAGAGAGAGTAAGAGTATTTGTATCTAAATTGGATTAGAATAATTTTTTTCATGTCCCTTTACTTTCCTGTAGCTTGCTGATGACCGTATGGCACTGGTGTCAGGCATCAGCTTAGATCCAGAAGCAGCGATTGGTGTGACAAAACGGCCACCTCCTAAGTGGGTGGATGGAGTGGATGAAGTAAGTTCCATGTTAGTTTCATAGCATCTTGTTTTTTTAAGTAATTATGACAATGTATTTTAAGATATCTGTCATATAAACGAATTTGGCTACACTTGAATGTATATTTCTAGAAATACTTTAGCTTTAGGTTAAGTTGTCTATGTGTGTGTTAATGATTTTAGCTGTAGTTTTAACATTGGTAGTAACTACCTGAATTATAGGAAGAAATTGAAACCCCATGCAACAAGGAAGAATGTGATTTTCTGGTAATTTGAATTAAAAGCTGCTCACACATCAGCAAGCCAACAAGTTTGCTGAAGACCGAATTCTGTATGCTGAGTGTAGCTGATGGAGGCAGACCATAGCCTGCCTGGCATCAGTGGAGTTCTGTGACTTCATTTGCTTAGATTCAGTATGATGTTGGCCGGATTAAGCAGAAGATGAAAGAATTGGCCAGCCTTCATGACAAGCATTTAAACAGACCCACCCTGGATGACAGCAGCGAAGAGGAACATGCCATTGAGATAACTACCCAAGAGATCACTCAGGTGAGGAGTGCAAGTGAGTCCTGGGGAAACCAGCGAGCCTTCTCATGGCAATCTCAGAAACTAGAGTGTTACTCAGAATCAGTCTCCTGGAGTCATTTCCCAACCTGAAGTTCTCAGAGGGACCTCAAGAGGCCCTGAAGTCCTCCAGCTGTCAGCGTAGGTACCTGTGAGGCCTTGGAGGTATGGGGACTGTTTTTCAATTGTTGGCAGATAACTGCTGTGGACGGATTAAGTAAATATGAAATTTCAAACATTATCGAGTTCAATCATTTGATTTTAAAATGTATAACTAATATCGTATACTAGTGTTAAGAAATTTCAATGCTAAATTATAGTCCTCATAATTGAAAAAACAACTTAGTATCCTAGAAAAAATTTTTTATAAATATTAAATTTGATTAATTTTAAAATAATAGGACTAGTGTTGAAACCTCAGTGTTTACATTTTTTACTGAAGTCTCCTGGGTGCTAATTATCAGAGGAGTGTGGTGCTTTGAGAAAAGCCCTGGGGGGTTGGAATGTTGGAACCCTGGCTCTTAGCAGTTTAACAGTTACACGATTCTCATTTAATCCCTCTGACTCTAGTGTTCTCATCTGTAAAATGGGACTAATAATCATAGTACCATCCTCATAGGATGCTTGTTAGGGATTAAATGAGAGGAATGCAATAATAATATGATATATGATAATACAGGTTGAACATTCCTAATCTGAAATCCAAAATGCTCCAAAATTTGAAACTTTCTTTTGAGTGCCAATATGACACTCAAAGGAATGCTCATTGGAGCATTTTGGATTTCGAATTTTCAGATTGGGGTACTCAACTAGTAGGTATTCTGCAAATATTCCAAAATCTCCCGAAATTTGAAATCCTAAACATTGCCAATCCCAAGCATTTCGGATGAGGGATACTCAGCCTGTCTAACGTGATGATATGTGAGCAGCTGGGCACACAGCAGGCCCTACATAGCAGGAGCTGAAATCTAGTGAAATCTTTCTGTGTATATAAATGAAGCCACAGATTCCTTTTATCTGTTCACCTTTCTCTAAACCAGACTGAGTGAACAGAGCCTCTCACTTCTCACTCTGGCTTGTGATGTGGCAGTGTTAGCAGAGGGGCTTCTCTCCCAGGCTTGCCCTGAGCCTCGGGCTTGTTCTCTTAGCTCTTCCACAGGTGCCAGCGTGCCGTGCAGGCCCTGCCGAGCCGGGCCCGGGCCTGCTCCGAGCAGGAGGGGCGGCTGCTTGGGAACGTGGTGGCCTCGCTGGCGCAGGCCCTGCAGGAACTCTCCACCAGCTTCCGGCACGCACAGTCAGGCTACCTCAAACGTGAGTGCTGCCCGGGCCTAGTGAAGGGATTTTGAGTAAGAAAAGCACTTTATGTTTTCTTTTTTGCCACTATTTTTTCATTTAGTCCAGTACCTTTCATTGTTAGCTTTTGAACATGCTCATACCTTGTACAGTAAAGGGAAGCCTCCTCCCCATGTGAAACCCTGGCTTGGAATGAAGGCACAGCGTGGGGTACCGACCAAGGCTGGGGGAGGGCACCAAGATAGTTCAGCATCTCAGCAAACAAAATTTGTTTTGTGTCAAGCTGCAAGAATTTGAAAATCAACCAAGCACATTTTAAAAACCTGTTGTTTTCTGGATGTTGGGGTTTGGGAGAGCTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57240484" stop="57244850" display_start="57240484" display_stop="57244850" variantLength="4367" positionVCF="57240483" referenceAlleleVCF="CCTTTGAGGGTGGAAGGGGTTTCTGGAGTCAGCCGACCCAGGTTTCAGTCTGTCACATAATGGCTCTGTGACCTTGGGCAAGCGACTTAACTTTTCTGAGTTTCAATTTCCATATTTATAGGTTAGAATAATAGTTTCTAACTCACCTAGTTTTTATGAGGATTAAAATAATGTCAAGAATGTAAAATTCCTATTGATGAACTCTTGAAACCAAACAGAAGGTAGTGGTGGTGGAGAATTACCACTTCACGGCCCGGGAGCCCCAGACAGTGCGGGTTTGGATGACACACCATTTGTTTAAGAAATGACACTGGCCCTGCAGCATCCGTGCCACGCTTGAGCACCGTTGGGCTTAATCACGGCTCCTGGACGTGCTGGGATTAGTGAATGGGGCCTAGTCCTTCCAGCGTGGTCATTGCCTAAGATGCGTTCCCTGAGTGGACACGTGCCCCAGAGCACACAGAAAGCCTGAAGCAGATGGTGGCAGAACCACTCCAGGGCATGCAGGGAGGTTGATGGTGAAGATACCAATTTGCTTTTAAGAATTTTACTGTGAACTCTTTAGGATTTAGGGCCTATTACTTGAAGTGGTCTTTTATTCTAAGTTTTTCTTTATATGATATTTTTCCCCCTTCATCTGTGGATTTTAAAATTTTGTCTTGTTCCTTTATTATTAGAAAAGCAAATAAGTATTTAATGAATGAAAAAATAAATTTAGTTAAATGCAAGGAAGAGGGAAGAAAAGCAATATGAATTTTTCACCCAACTCTACAGTGTGATTTAGAAAATTTCCAAAGTATTATCTATAAAGGGCTTTTATAGATTATTTTCCATTATATTTTGATCATCATTTGGATCTTTTGAAACTGGCATTTAAAAATTCTGAGCTCTGGAGGGCACCTCAAAATCTTTTCAACCCATTCACTGCCTGCAGGCAAGAAAACAGCTTAACCGTGCCAAACCCATGATTTCCCTCTGTTTTTTGTGTGTGTGTGTGTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTTTCGCTCTTGTTGCCCTGGCTGGAGTGCAATGGTACGATCATGGCTCACTGCGACCTTCGCCTCTTGGGTTCAAGGGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGCATAAGCCACCATGCCCAGTTAATTTTTGTATTTTTAGTAGAGAACGGTTTTCACCATTTTGGCCAGGCTACTCTCGAACTCCTGACCTCAGATGATCTGCCCGCCTTGGCCTCCCAAAGTTCTGGGATTACAGGCGTGAGCCACCGCGCCCAGCCGATTTCCCTCCCATTCTTAAAAGCTTTCTACCGCAGTGTGTTATATAGTTAAAATAAACAGGAACCATCGATACCATTTCAAAATAAGGGGAAATGTTCCCTGTGGACATTTAACTGAAGAAAAGAAATGACAGTGTAAGATTGCATTGAGATCTTAAGGATTGCTTTTGCCAAATGGTAGATAATTTGCTAGCGGTTTTAGGCAGTTGTTTCACACATCTTAACACATGGTTAATGATTGTGTGACTGAGATAACTGGATCAGCCCTATTTCCAAAATAAGCTAAGTGTATTTAAGTAAACCTTGCTACTATTGAGCATTTTGTAGTTGTTTCATTTACTGCCTAGTTTTTTTTTTCACTTGCAACTGATCACAAGAATCATTGAGGTTCATGCCGTTCTATCACAGTACTAGTAGTAAGAGGTCTTTATTTTAAGGATCTTTTGTTGACTTTTTCATTACATTTCTATAGCCAGATCAAGTCAAATTTACGTTCTGAAGTATGTCCAAGGAAATTAAGAGCTGGTGCATGAAAAGATAGGAAAACAATCCAAATCCTAGCAGTTATCAAAAGCAAGTTTATAATACAGGCAAGTGCATTCACTCCTTTCTATATATTTTCAGGGAGCAACATTTAAGAGAGAGTAAACATTCACTCCTTTCTGTATCTTTTCAGGGAGTAACATTTAAGAGAGAGTAAGAGTATTTGTATCTAAATTGGATTAGAATAATTTTTTTCATGTCCCTTTACTTTCCTGTAGCTTGCTGATGACCGTATGGCACTGGTGTCAGGCATCAGCTTAGATCCAGAAGCAGCGATTGGTGTGACAAAACGGCCACCTCCTAAGTGGGTGGATGGAGTGGATGAAGTAAGTTCCATGTTAGTTTCATAGCATCTTGTTTTTTTAAGTAATTATGACAATGTATTTTAAGATATCTGTCATATAAACGAATTTGGCTACACTTGAATGTATATTTCTAGAAATACTTTAGCTTTAGGTTAAGTTGTCTATGTGTGTGTTAATGATTTTAGCTGTAGTTTTAACATTGGTAGTAACTACCTGAATTATAGGAAGAAATTGAAACCCCATGCAACAAGGAAGAATGTGATTTTCTGGTAATTTGAATTAAAAGCTGCTCACACATCAGCAAGCCAACAAGTTTGCTGAAGACCGAATTCTGTATGCTGAGTGTAGCTGATGGAGGCAGACCATAGCCTGCCTGGCATCAGTGGAGTTCTGTGACTTCATTTGCTTAGATTCAGTATGATGTTGGCCGGATTAAGCAGAAGATGAAAGAATTGGCCAGCCTTCATGACAAGCATTTAAACAGACCCACCCTGGATGACAGCAGCGAAGAGGAACATGCCATTGAGATAACTACCCAAGAGATCACTCAGGTGAGGAGTGCAAGTGAGTCCTGGGGAAACCAGCGAGCCTTCTCATGGCAATCTCAGAAACTAGAGTGTTACTCAGAATCAGTCTCCTGGAGTCATTTCCCAACCTGAAGTTCTCAGAGGGACCTCAAGAGGCCCTGAAGTCCTCCAGCTGTCAGCGTAGGTACCTGTGAGGCCTTGGAGGTATGGGGACTGTTTTTCAATTGTTGGCAGATAACTGCTGTGGACGGATTAAGTAAATATGAAATTTCAAACATTATCGAGTTCAATCATTTGATTTTAAAATGTATAACTAATATCGTATACTAGTGTTAAGAAATTTCAATGCTAAATTATAGTCCTCATAATTGAAAAAACAACTTAGTATCCTAGAAAAAATTTTTTATAAATATTAAATTTGATTAATTTTAAAATAATAGGACTAGTGTTGAAACCTCAGTGTTTACATTTTTTACTGAAGTCTCCTGGGTGCTAATTATCAGAGGAGTGTGGTGCTTTGAGAAAAGCCCTGGGGGGTTGGAATGTTGGAACCCTGGCTCTTAGCAGTTTAACAGTTACACGATTCTCATTTAATCCCTCTGACTCTAGTGTTCTCATCTGTAAAATGGGACTAATAATCATAGTACCATCCTCATAGGATGCTTGTTAGGGATTAAATGAGAGGAATGCAATAATAATATGATATATGATAATACAGGTTGAACATTCCTAATCTGAAATCCAAAATGCTCCAAAATTTGAAACTTTCTTTTGAGTGCCAATATGACACTCAAAGGAATGCTCATTGGAGCATTTTGGATTTCGAATTTTCAGATTGGGGTACTCAACTAGTAGGTATTCTGCAAATATTCCAAAATCTCCCGAAATTTGAAATCCTAAACATTGCCAATCCCAAGCATTTCGGATGAGGGATACTCAGCCTGTCTAACGTGATGATATGTGAGCAGCTGGGCACACAGCAGGCCCTACATAGCAGGAGCTGAAATCTAGTGAAATCTTTCTGTGTATATAAATGAAGCCACAGATTCCTTTTATCTGTTCACCTTTCTCTAAACCAGACTGAGTGAACAGAGCCTCTCACTTCTCACTCTGGCTTGTGATGTGGCAGTGTTAGCAGAGGGGCTTCTCTCCCAGGCTTGCCCTGAGCCTCGGGCTTGTTCTCTTAGCTCTTCCACAGGTGCCAGCGTGCCGTGCAGGCCCTGCCGAGCCGGGCCCGGGCCTGCTCCGAGCAGGAGGGGCGGCTGCTTGGGAACGTGGTGGCCTCGCTGGCGCAGGCCCTGCAGGAACTCTCCACCAGCTTCCGGCACGCACAGTCAGGCTACCTCAAACGTGAGTGCTGCCCGGGCCTAGTGAAGGGATTTTGAGTAAGAAAAGCACTTTATGTTTTCTTTTTTGCCACTATTTTTTCATTTAGTCCAGTACCTTTCATTGTTAGCTTTTGAACATGCTCATACCTTGTACAGTAAAGGGAAGCCTCCTCCCCATGTGAAACCCTGGCTTGGAATGAAGGCACAGCGTGGGGTACCGACCAAGGCTGGGGGAGGGCACCAAGATAGTTCAGCATCTCAGCAAACAAAATTTGTTTTGTGTCAAGCTGCAAGAATTTGAAAATCAACCAAGCACATTTTAAAAACCTGTTGTTTTCTGGATGTTGGGGTTTGGGAGAGCTG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>3-KB TO 4.4-KB MICRODELETION</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.57240486_57244852del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.57240486_57244852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.58665430_58669796del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.58665430_58669796del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011831.2" sequenceAccession="NG_011831" sequenceVersion="2" change="g.19159_23525del">
            <Expression>NG_011831.2:g.19159_23525del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011831.3" sequenceAccession="NG_011831" sequenceVersion="3" change="g.19149_23515del">
            <Expression>NG_011831.3:g.19149_23515del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_143654.1" sequenceAccession="NG_143654" sequenceVersion="1" change="g.1_564del">
            <Expression>NG_143654.1:g.1_564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001001433.3" sequenceAccession="NM_001001433" sequenceVersion="3" change="c.145-2060_556+343del" MANESelect="true">
            <Expression>NM_001001433.3:c.145-2060_556+343del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134772.3" sequenceAccession="NM_001134772" sequenceVersion="3" change="c.133-2060_544+343del">
            <Expression>NM_001134772.3:c.133-2060_544+343del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134773.3" sequenceAccession="NM_001134773" sequenceVersion="3" change="c.94-2060_505+343del">
            <Expression>NM_001134773.3:c.94-2060_505+343del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003763.6" sequenceAccession="NM_003763" sequenceVersion="6" change="c.82-2060_493+343del">
            <Expression>NM_003763.6:c.82-2060_493+343del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204868.2" sequenceAccession="NM_001204868" sequenceVersion="2" change="c.-15-2060_397+343del">
            <Expression>NM_001204868.2:c.-15-2060_397+343del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603666.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Allelic variant 603666.0001 describes multiple deletions in STX16 that include exon 4.  NCBI staff selected the 4.4 kb variant reported in the paper by Linglart et al., 2005 (PubMed 15800843) to provide a representative HGVS expression.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001001433.3(STX16):c.145-2060_556+343del AND Pseudohypoparathyroidism type 1B" Accession="RCV000006524" Version="2">
        <ClassifiedConditionList TraitSetID="321">
          <ClassifiedCondition DB="MedGen" ID="C1864100">Pseudohypoparathyroidism type 1B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2023-09-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14561710</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15579741</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15800843</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="321" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4057" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pseudohypoparathyroidism Type IB</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHP IB</ElementValue>
                <XRef Type="MIM" ID="603233" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudohypoparathyroidism type 1B</ElementValue>
                <XRef ID="Pseudohypoparathyroidism+type+1B/6036" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011301" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHP1B</ElementValue>
                <XRef Type="MIM" ID="603233" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.</Attribute>
                <XRef ID="NBK459117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10680" />
                <XRef ID="10680" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29072892</ID>
                <ID Source="BookShelf">NBK459117</ID>
              </Citation>
              <XRef ID="94089" DB="Orphanet" />
              <XRef ID="C1864100" DB="MedGen" />
              <XRef ID="MONDO:0011301" DB="MONDO" />
              <XRef Type="MIM" ID="603233" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26707" SubmissionDate="2009-01-07" DateLastUpdated="2023-09-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603666.0001_PSEUDOHYPOPARATHYROIDISM, TYPE IB" title="STX16, 3-KB TO 4.4-KB MICRODELETION _PSEUDOHYPOPARATHYROIDISM, TYPE IB" />
        <ClinVarAccession Accession="SCV000026707" DateUpdated="2023-09-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members and obligate carriers of 12 unrelated families with pseudohypoparathyroidism type Ib (603233), Bastepe et al. (2003) identified a 3-kb heterozygous microdeletion located approximately 220 kb centromeric of exon 1A, which they called exon A/B, of the GNAS gene (see also 139320.0031). Four of 16 apparently sporadic patients also had the deletion. Affected individuals with the microdeletion showed loss of exon 1A methylation, but no other epigenetic abnormalities. In all examined cases, the deletion was inherited from the mother, consistent with the observation of PHP Ib developing only in offspring of female obligate carriers. The deletion removed 3 of 8 exons encoding STX16, but Bastepe et al. (2003) considered the involvement of STX16 in the molecular pathogenesis of PHP Ib unlikely. They postulated that the microdeletion disrupts a putative cis-acting control element required for methylation at exon 1A and that this epigenetic defect underlies the pathogenesis of PHP Ib.</Attribute>
              <Citation>
                <ID Source="PubMed">14561710</ID>
              </Citation>
              <XRef DB="OMIM" ID="603233" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Laspa et al. (2004) reported a Greek PHP Ib kindred with 4 affected members and 3 obligate carriers who had the 3-kb deletion within STX16. Symptomatic hypocalcemia was present only in the proband, but PTH was elevated in all members who had inherited the 3-kb deletion maternally. In all affected family members, urinary phosphate excretion was normal, but 1,25-dihydroxyvitamin D levels were diminished. Affected individuals displayed hypouricemia with increased fractional excretion of uric acid, suggesting possible involvement of PTH in the renal handling of this metabolite.</Attribute>
              <Citation>
                <ID Source="PubMed">15579741</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In all affected individuals and obligate carriers in a large kindred with PHP Ib, Linglart et al. (2005) identified a 4.4-kb microdeletion overlapping with a region of the 3-kb deletion identified by Bastepe et al. (2003). The 4.4-kb deletion removed exons 2-4 of the STX16 gene, whereas the 3-kb deletion removed exons 4-6. Both microdeletions lead to PHP Ib only after maternal transmission, and affected individuals exhibit loss of methylation only at GNAS exon A/B. Linglart et al. (2005) determined that the STX16 gene is not imprinted, and proposed that the region of overlap between the microdeletions contains a cis-acting imprinting control element that is necessary for establishing and/or maintaining methylation at GNAS exon A/B.</Attribute>
              <Citation>
                <ID Source="PubMed">15800843</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">14561710</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="STX16" />
          </GeneList>
          <Name>STX16, 3-KB TO 4.4-KB MICRODELETION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-KB TO 4.4-KB MICRODELETION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603666.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PSEUDOHYPOPARATHYROIDISM, TYPE IB</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26707" TraitType="Disease" MappingType="Name" MappingValue="PSEUDOHYPOPARATHYROIDISM, TYPE IB" MappingRef="Preferred">
        <MedGen CUI="C1864100" Name="Pseudohypoparathyroidism type 1B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

